1. Home
  2. VRTX vs TT Comparison

VRTX vs TT Comparison

Compare VRTX & TT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated

HOLD

Current Price

$455.90

Market Cap

115.7B

Sector

Technology

ML Signal

HOLD

Logo Trane Technologies plc

TT

Trane Technologies plc

HOLD

Current Price

$421.75

Market Cap

102.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRTX
TT
Founded
1989
1885
Country
United States
Ireland
Employees
N/A
N/A
Industry
EDP Services
Auto Parts:O.E.M.
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
115.7B
102.6B
IPO Year
2006
2009

Fundamental Metrics

Financial Performance
Metric
VRTX
TT
Price
$455.90
$421.75
Analyst Decision
Buy
Buy
Analyst Count
27
14
Target Price
$526.79
$480.00
AVG Volume (30 Days)
1.3M
1.1M
Earning Date
01-01-0001
04-30-2026
Dividend Yield
N/A
0.96%
EPS Growth
836.54
15.48
EPS
15.32
12.98
Revenue
$2,488,652,000.00
$14,782,000,000.00
Revenue This Year
$10.79
$12.09
Revenue Next Year
$10.14
$8.04
P/E Ratio
$30.10
$33.52
Revenue Growth
46.20
5.58
52 Week Low
$362.50
$298.15
52 Week High
$519.68
$479.37

Technical Indicators

Market Signals
Indicator
VRTX
TT
Relative Strength Index (RSI) 42.72 39.18
Support Level $455.62 $420.73
Resistance Level $465.98 $427.93
Average True Range (ATR) 13.17 10.54
MACD -2.82 -6.28
Stochastic Oscillator 13.47 5.89

Price Performance

Historical Comparison
VRTX
TT

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

About TT Trane Technologies plc

Trane Technologies manufactures and services commercial and residential HVAC systems and transportation refrigeration solutions under its prominent Trane, American Standard, and Thermo King brands. The company generates approximately 70% of sales from equipment and 30% from parts and services. While the firm is domiciled in Ireland, North America accounts for approximately 80% of its revenue, with 13% from EMEA and 7% Asia-Pacific. The company was formed in 2020 when its former parent, Ingersoll Rand, merged with Gardner Denver in a tax-advantaged reverse Morris trust transaction.

Share on Social Networks: